On June 9, 2026, Everest Medicines (HKEX: 1952) announced that it had entered into an agreement with Jiangsu Vcare PharmaTech Co., Ltd. ("Vcare PharmaTech"), under which Everest Medicines obtained the exclusive rights to develop, register and commercialize Sumecigrel (formerly known as Vicagrel), a P2Y12 receptor antagonist, in multiple countries and regions across Asia-Pacific, including Southeast Asia, South Korea, Australia, Hong Kong Special Administrative Region, Macau Special Administrative Region and Taiwan region, China. Pursuant to the agreement, Everest Medicines will pay Vcare PharmaTech an upfront payment of RMB 20 million, along with subsequent milestone payments and commercial supply procurement.
Sumecigrel is an antiplatelet agent and a new-generation oral P2Y12 receptor antagonist. It is being clinically developed for the treatment and prevention of atherothrombotic events such as acute coronary syndrome (ACS), ischemic stroke (IS) and peripheral arterial disease (PAD). As a novel antithrombotic drug developed by Vcare PharmaTech, the product is currently advancing preparations for NDA in China, the United States, Europe.
Han Kun acted as legal counsel to Everest Medicines in this transaction and provided comprehensive legal services throughout the process. The team was led by Yang (Aaron) Gu, comprising Fengqi (Franky) Yu, Xiaofu Ning and Lingyu Sheng, and was deeply involved in key stages of the transaction, including the drafting and revision of the agreement. Dr. Ying Li and Jingya Guo, from Han Kun's Intellectual Property team, provided support on IP-related matters. This project highlights Han Kun's outstanding capabilities in handling complex deals in the life sciences and healthcare sectors.
About Everest Medicines
Everest Medicines is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative pharmaceutical products that address critical unmet medical needs for patients in global markets. The management team of Everest Medicines has deep expertise and an extensive track record both in China and with leading global pharmaceutical companies.
The Company's therapeutic areas of focus include CKM (cardiovascular, kidney, and metabolic), autoimmune, ophthalmology and critical care. Everest Medicines has developed a fully integrated commercialization platform that combines omnichannel commercial capabilities with end-to-end product lifecycle management. Leveraging its proprietary mRNA platform, the Company is advancing its existing pipeline, including mRNA in vivo CAR-T and mRNA cancer vaccines, while selectively expanding into additional high-value therapeutic areas with blockbuster potential, and accelerating its global expansion. For more information, please visit the Company's website: www.everestmedicines.com.
Han Kun's Life Sciences and Healthcare Practice
Han Kun is widely recognized and well-known for its practice in life sciences and healthcare. In relevant practice areas, we have been continuously ranked as a first-tier law firm by authoritative legal ranking agencies, including Chambers and Partners, The Legal 500, China Business Law Journal, Asialaw Profiles, etc. Han Kun is committed to providing clients with comprehensive legal services in life sciences and healthcare sector, including private equity and venture capital, mergers and acquisitions, onshore and offshore capital market, pharmaceutical license in/out and asset sale/purchase transactions, intellectual property, data protection, compliance and regulatory, and dispute resolution. Han Kun has a dedicated life sciences and healthcare team led by multiple partners and comprised of tens of specialist attorneys. Our partners on the team all have served a broad range of both domestic and foreign clients and developed a deep understanding of industry regulatory requirements and commercial course of dealings. Our associates on the team are graduates from top law schools both in China and abroad, all fluent in Chinese and English and equipped with excellent legal writing skills. Han Kun is well aware of the importance of professional legal services for life sciences and healthcare companies, especially those facing complex legal issues and therefore requiring special legal support. Clients value our teamwork as we fully leverage the expertise and experience of our professionals, all experts in their respective fields. Our goal is always to provide clients with thorough and practical solutions and high-quality legal services.
